Skip to main navigation Skip to search Skip to main content

A Phase II NCCTG study of irinotecan and docetaxel in previously treated patients with non-small cell lung cancer

  • Julian Molina
  • , Daniel Nikcevich
  • , Shauna Hillman
  • , Susan Geyer
  • , Timothy Drevyanko
  • , James Jett
  • , Joseph Verdirame
  • , Henry Tazelaar
  • , Kendrith Rowland
  • , Edward Wos
  • , Leila Kutteh
  • , Suresh Nair
  • , Tom Fitch
  • , Patrick Flynn
  • , Philip Stella
  • , Alex Adjei

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'A Phase II NCCTG study of irinotecan and docetaxel in previously treated patients with non-small cell lung cancer'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Medicine and Dentistry